Video

Audience Q&A: Best Practices in Managing HER2-Amplified CRC

Author(s):

Tanios Bekaii-Saab, MD, FACP, Mayo Clinic,Cathy Eng, MD, Vanderbilt University

Fielding questions from the audience, expert oncologists discuss clinical trials, molecular testing, and early-stage disease in the context of HER2-amplified colorectal cancer.

Related Videos
Grzegorz S. Nowakowski, MD, and Samuel Yamshon, MD, break down the current treatment landscape for relapsed/refractory follicular lymphoma.
Javier Pinilla, MD, PhD, and Talha Badar, MBBS, MD, discuss factors that influence later-line treatment choices in chronic myeloid leukemia.
Javier Pinilla, MD, PhD, and Talha Badar, MBBS, MD, on the implications of the FDA approval of asciminib in newly diagnosed CP-CML.
Nosha Farhadfar, MD, and Chandler Park, MD, FACP
Shaji Kumar, MD
Shaji Kumar, MD
Related Content
FDA
December 20th 2024

FDA Grants Accelerated Approval to Encorafenib Plus Cetuximab and Chemo for BRAF V600E+ Metastatic Colorectal Cancer

Binod Dhakal, MD, associate professor, medicine, Division of Hematology, Medical College of Wisconsin; Muhamed Baljevic, MD, associate professor, medicine, Division of Hematology Oncology, director, Plasma Cell Disorders Research, director, Vanderbilt Amyloidosis Multidisciplinary Program, co-chair, Protocol Review and Monitoring System, disease team lead, plasma cell dyscrasias and lymphomas, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
December 6th 2024

How to Optimize Patient Selection for Multiple Myeloma Therapies: With Binod Dhakal, MD; and Muhamed Baljevic, MD

Cathy Eng, MD, FACP, FASCO
December 6th 2024

NGS and ctDNA Testing Guide Treatment Selection and Sequencing in mCRC

Delve into Recent NCCN Guideline Updates for Hepatobiliary and CRC Management: With Alan P. Venook, MD
October 24th 2024

Delve into Recent NCCN Guideline Updates for Hepatobiliary and CRC Management: With Alan P. Venook, MD

Alan P. Venook, MD, of UCSF
November 27th 2024

Targeted Therapies Represent Core 2024 NCCN GI Cancer Guideline Advancements

The Microbiome and Colon Cancer | Image Credit: © Anatomy Insider - stock.adobe.com
November 25th 2024

The Microbiome and Colon Cancer: Dietary Influence on Incidence, Morbidity, and Mortality